Skip to content
VulniPulse
Medium6.5Red Hat Linux

Medium [CVE-2026-4629] Keycloak: keycloak: privilege escalation through hardcoded role mapper injection

This medium-severity Red Hat Linux advisory covers CVE-2026-4629 affecting Red Hat build of Keycloak 26.4.

CVE-2026-4629 Published Jun 30, 2026Updated by vendor Aug 5, 2026
Affected products & platforms
Red Hat LinuxUnclassified
Open vendor advisory

Android app · Google Play

Monitor future Red Hat Linux CVEs from your phone.

Choose a whole vendor or a precise platform, then receive matching security advisories by phone notification, email, or both. Coverage follows 32 official vendor sources and 160+ reviewed platform categories.

Matching phone alertsOptional email delivery

Summary

A flaw was found in Keycloak. A highly privileged user with `manage-clients` permission can exploit this vulnerability by injecting a hardcoded role mapper into any client.

This action allows the user to bypass existing scope restrictions and inject the `realm-admin` role into generated tokens, resulting in privilege escalation and full administrative access to the realm.

Affected product named by the advisory: Red Hat build of Keycloak 26.4.

Affected versions

No affected-version range was extracted from the source record. The vendor advisory is authoritative — check it before change work.

Official advisory · medium-confidence parse· fetched 2 hours ago·verify at source

Fixed versions

No fixed release is recorded yet. That does not prove no patch exists — confirm against the vendor advisory.

Official advisory · medium-confidence parse· fetched 2 hours ago·verify at source

Mitigation

The source record does not include mitigation steps. That is not a statement that no fix exists — read the vendor advisory below for the authoritative guidance.

Official advisory · medium-confidence parse· fetched 2 hours ago·verify at source

Discussion(0)

No comments yet. Share field notes, upgrade gotchas, or questions — verify against the vendor advisory before acting on community advice.

Sign in to join the discussion.